Diabetes study - Illustration

An Investigational Diabetes Treatment

Join this study and help develop a therapy for treating
type II diabetes and weight loss.

Weight control is key to managing blood sugar levels for patients suffering from type II diabetes. This study is examining a once daily investigational GLP-1 medication for patient who currently treat their Type 2 Diabetes with diet and exercise alone.

If you are at least 18 years old and HAVE NOT used insulin to treat your Type 2 Diabetes you could qualify for this clinical research study.

Those that qualify and choose to participate may receive up to $3,248 for their time.

dialogue icon

Medical Oversight

  • 24-hour access to MBR’s doctors/medical staff.
  • World class medical oversight.
  • Free of Charge!
like icon

No cost

  • Insurance is NOT required to participate.
  • No cost services include:
    – Study related medication
    – Doctor’s visits
    – Physical exams
    – Testing
coins icon


  • Those who qualify and choose to participate may receive a $3,248 stipend.
Monroe Biomedical Research - Hero
“By participating in research, Diabetes patients join the fight against this debilitating disease.”


Learn More
Register Today

The first step is to learn more and see if you qualify. After registering, a clinical research coordinator will contact you and answer your questions

Sign up using the link below

Call or text +1 704 283 7359


Visit Our Center
See If You Qualify

Our facility is state of the art.

Visit our center for a prescreening visit to see if you qualify.


What our Patients say about our services

Research facility

Monroe Biomedical


Square feet Dedicated Research Facility


Recreational Area Comfortable Recliners


Free entertainment options


First Class Service from our Nurses and Staff

Free entertainment

Movies and Shows
Personal Tablets
Large Flatscreen TV

High Speed Wifi

Family Friendly

Very Comfortable

Diabetes study - Illustration

Diabetes Study

The main purpose of this study is to determine safety and efficacy of orforglipron compared with placebo in adult participants with type 2 diabetes and inadequate glycemic control with diet and exercise alone. The study will last approximately 54 weeks.


Click here for more information

Contact Us

Monroe Biomedical Research
343 Venus Street, Monroe, NC 28112

Office Phone: 704-283-7369
Fax: 704-283-7329
Email: patients@monroeresearch.com


Frequently Asked Questions

What does diabetes mean?
  • Diabetes is a life-long health condition in which the body is not able to produce the right amount of insulin. This can result in high blood sugar. Over time high blood glucose could cause severe problems in the heart, kidney, eye, dental, and nerves. Three types of diabetes are distinguished depending on the causes, medical treatments, and the affected patient group.
Can diabetes be cured?
  • Although a diabetes cure does not exist at the moment, there are steps to manage the condition and live a healthy lifestyle. By joining our study you could join the fight against this debilitating disease.
What does Type 2 diabetes mean?
  • The most common type of diabetes is Type 2. This means the body can’t produce enough insulin at all. You are at higher risk of developing Type 2 Diabetes if you have a family history of diabetes or are overweight. Suffering from Type 2 Diabetes is a progressive condition and diabetes therapies may be required.
What if I am uninsured?
  • Proof of insurance is NOT required to participate in this study. All medical oversight over the course of your study participation is included.
What does investigational medication mean?
  • An Investigational medication (also known as investigational new drug) has been approved by the Food and Drug Administration (FDA) for testing in people in a clinical study, but has not been approved for general use, distribution or sale. It is through clinical research that these medications receive full approval by the FDA.
How will I be compensated for participating?
  • Participants receive a check following each study visit. For this study, those that qualify and choose to participate could receive a stipend up to $1775.
Share via
Copy link